Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression

Virology Journal

Volumn 3, Issue , 2006, Pages

  Kaukinen, Pasi ^a   Sillanpää, Maarit ^a   Kotenko, Sergei ^b   Lin, Rongtuan ^c   Hiscott, John ^c   Melén, Krister ^a   Julkunen, Ilkka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CARDIF PROTEIN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERLEUKIN 29; INTERLEUKIN 8; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; PROTEIN; RANTES; RIG 1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HOST CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; NONHUMAN; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SENDAI VIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; CYTOKINES; DEAD-BOX RNA HELICASES; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEPACIVIRUS; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; MITOCHONDRIAL MEMBRANES; PROMOTER REGIONS, GENETIC; RNA HELICASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; IPS; RNA VIRUSES; SENDAI VIRUS;

EID: 33748741785     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-66     Document Type: Article

References (46)

1. Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM: Structural biology of hepatitis C virus. Hepatology 2004, 39(1):5-19.
2. Xu Z, Choi J, Yen TS, Lu W, Strohecker A, Govindarajan S, Chien D, Selby MJ, Ou J: Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. Embo J 2001, 20(14):3840-3848.
3. Foy E, Li K, Wang C, Sumpter RJ, Ikeda M, Lemon SM, Gale MJ: Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003, 300(5622):1145-1148.
4. Marie I, Durbin JE, Levy DE: Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. Embo J 1998, 17(22):6660-6669.
5. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413(6857):732-738.
6. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5(7):730-737.
7. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T: TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 2003, 4(2):161-167.
8. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S: IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005, 6(10):981-988.
9. Seth RB, Sun L, Ea CK, Chen ZJ: Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122(5):669-682.
10. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB: VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005, 19(6):727-740.
11. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J: Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437(7062):1167-1172.
12. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T: IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003, 4(5):491-496.
13. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J: Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300(5622):1148-1151.
14. Breiman A, Grandvaux N, Lin R, Ottone C, Akira S, Yoneyama M, Fujita T, Hiscott J, Meurs EF: Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. J Virol 2005, 79(7):3969-3978.
15. Foy E, Li K, Sumpter RJ, Loo YM, Johnson CL, Wang C, Fish PM, Yoneyama M, Fujita T, Lemon SM, Gale MJ: Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A 2005, 102(8):2986-2991.
16. Sumpter RJ, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale MJ: Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 2005, 79(5):2689-2699.
17. Ferreon JC, Ferreon AC, Li K, Lemon SM: Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. J Biol Chem 2005, 280(21):20483-20492.
18. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale MJ, Lemon SM: Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 2005, 102(8):2992-2997.
19. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ: Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 2005, 102(49):17717-17722.
20. Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM, Carney DS, Wang T, Ishida H, Yoneyama M, Fujita T, Saito T, Lee WM, Hagedorn CH, Lau DT, Weinman SA, Lemon SM, Gale MJ: Viral and therapeutic control of IFN-{beta} promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 2006.
21. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M, Tschopp J: RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 2004, 5(5):503-507.
22. Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, Sen GC: Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 2004, 11(11):1060-1067.
23. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S: Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002, 169(12):6668-6672.
24. Siren J, Pirhonen J, Julkunen I, Matikainen S: IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J Immunol 2005, 174(4):1932-1937.
25. Osterlund P, Veckman V, Siren J, Klucher KM, Hiscott J, Matikainen S, Julkunen I: Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol 2005, 79(15):9608-9617.
26. Veckman V, Osterlund P, Fagerlund R, Melen K, Matikainen S, Julkunen I: TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 2006, 345(1):96-104.
27. Siren J, Imaizumi T, Pietila T, Lin R, Hiscott J, Noah DL, Krug RM, Sarkar D, Fisher PB, Julkunen I, Matikainen S: RIG-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. Microbes Infect 2006, in press:.
28. Matikainen S, Siren J, Tissari J, Veckman V, Pirhonen J, Severa M, Sun Q, Lin R, Meri S, Uze G, Hiscott J, Julkunen I: Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol 2006, 80(7):3515-3522.
29. Wolk B, Sansonno D, Krausslich HG, Dammacco F, Rice CM, Blum HE, Moradpour D: Subcellular localization, stability, and transcleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol 2000, 74(5):2293-2304.
30. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff Z, Chapman MJ, Miyamura T, Brechot C: Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 1997, 94(4):1200-1205.
31. Moradpour D, Englert C, Wakita T, Wands JR: Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 1996, 222(1):51-63.
32. Melen K, Fagerlund R, Nyqvist M, Keskinen P, Julkunen I: Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs. J Med Virol 2004, 73(4):536-547.
33. Brass V, Bieck E, Montserret R, Wolk B, Hellings JA, Blum HE, Penin F, Moradpour D: An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J Biol Chem 2002, 277(10):8130-8139.
34. Gale MJ, Foy EM: Evasion of intracellular host defence by hepatitis C virus. Nature 2005, 436(7053):939-945.
35. Dumoulin FL, von dem Bussche A, Li J, Khamzina L, Wands JR, Sauerbruch T, Spengler U: Hepatitis C virus NS2 protein inhibits gene expression from different cellular and viral promoters in hepatic and nonhepatic cell lines. Virology 2003, 305(2):260-266.
36. Yamaga AK, Ou JH: Membrane topology of the hepatitis C virus NS2 protein. J Biol Chem 2002, 277(36):33228-33234.
37. Hugle T, Fehrmann F, Bieck E, Kohara M, Krausslich HG, Rice CM, Blum HE, Moradpour D: The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology 2001, 284(1):70-81.
38. Franck N, Le Seyec J, Guguen-Guillouzo C, Erdtmann L: Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome. J Virol 2005, 79(5):2700-2708.
39. Erdtmann L, Franck N, Lerat H, Le Seyec J, Gilot D, Cannie I, Gripon P, Hibner U, Guguen-Guillouzo C: The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J Biol Chem 2003, 278(20):18256-18264.
40. Egger D, Wolk B, Gosert R, Bianchi L, Blum HE, Moradpour D, Bienz K: Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 2002, 76(12):5974-5984.
41. Seth RB, Sun L, Chen ZJ: Antiviral innate immunity pathways. Cell Res 2006, 16(2):141-147.
42. Pirhonen J, Sareneva T, Kurimoto M, Julkunen I, Matikainen S: Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol 1999, 162(12):7322-7329.
43. Melen K, Kinnunen L, Julkunen I: Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs. J Biol Chem 2001, 276(19):16447-16455.
44. Lin R, Heylbroeck C, Pitha PM, Hiscott J: Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 1998, 18(5):2986-2996.
45. Lin R, Heylbroeck C, Genin P, Pitha PM, Hiscott J: Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol Cell Biol 1999, 19(2):959-966.
46. Lin R, Genin P, Mamane Y, Hiscott J: Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol 2000, 20(17):6342-6353.